1. Home
  2. DRIO vs DXR Comparison

DRIO vs DXR Comparison

Compare DRIO & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DarioHealth Corp.

DRIO

DarioHealth Corp.

HOLD

Current Price

$6.82

Market Cap

52.8M

Sector

Health Care

ML Signal

HOLD

Logo Daxor Corporation

DXR

Daxor Corporation

HOLD

Current Price

$10.85

Market Cap

59.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DRIO
DXR
Founded
2011
1970
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
52.8M
59.0M
IPO Year
2013
1995

Fundamental Metrics

Financial Performance
Metric
DRIO
DXR
Price
$6.82
$10.85
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$35.00
N/A
AVG Volume (30 Days)
19.5K
8.7K
Earning Date
05-14-2026
02-27-2026
Dividend Yield
N/A
N/A
EPS Growth
1559.02
N/A
EPS
1.75
N/A
Revenue
$7,394,000.00
$1,446,345.00
Revenue This Year
$20.27
$44,935.22
Revenue Next Year
$47.58
$74.79
P/E Ratio
$4.02
$33.83
Revenue Growth
43.02
N/A
52 Week Low
$5.84
$8.56
52 Week High
$17.74
$14.76

Technical Indicators

Market Signals
Indicator
DRIO
DXR
Relative Strength Index (RSI) 45.97 56.73
Support Level $6.18 $9.26
Resistance Level $8.10 $10.99
Average True Range (ATR) 0.60 0.52
MACD -0.02 0.06
Stochastic Oscillator 29.19 82.80

Price Performance

Historical Comparison
DRIO
DXR

About DRIO DarioHealth Corp.

DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.

About DXR Daxor Corporation

Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system.

Share on Social Networks: